- Article
Systems Pharmacology and Network Analysis to Advance Pharmacogenomics and Precision Medicine Decisions in Type-2 Diabetes Therapy
- Aikaterini Saiti,
- Alexandros Giannopoulos-Dimitriou,
- Ioannis Kazakos,
- Eleftheria Galatou and
- Ioannis S. Vizirianakis
Diabetes mellitus type-2 (DMT2) molecular pathophysiology is still challenging since the disease represents a complex, multifactorial metabolic disease caused by polygenic defects and environmental factors. In addition, the resulting secondary organ...

